Neurol India Close
 

Figure 2: (a) The time course of NF-M alternations in the cerebrum following EAE. Representative immunoblots of NF-M are also shown below the graph. The 0-day control is presented with 100%, the one of the treated groups is described with the percentage of 0-day control. The results are presented as a mean percentage of 0-day control ± S.D. Statistical significance is determined by using one-way analysis of variance (ANOVA). The asterisk indicates statistical difference (* P < 0.05, **P < 0.01). (b) The time course of NF-M alternations in the spinal cord following EAE. Representative immunoblots of NF-M are also shown below the graph. The 0-day control is presented with 100%, the one of the treated groups is described with the percentage of 0-day control. The results are presented as a mean percentage of 0-day control ± SD. Statistical significance is determined by using one-way analysis of variance (ANOVA). The asterisk indicates statistical difference (* P < 0.05, **P < 0.01)

Figure 2: (a) The time course of NF-M alternations in the cerebrum following EAE. Representative immunoblots of NF-M are also shown below the graph. The 0-day control is presented with 100%, the one of the treated groups is described with the percentage of 0-day control. The results are presented as a mean percentage of 0-day control ± S.D. Statistical significance is determined by using one-way analysis of variance (ANOVA). The asterisk indicates statistical difference (<i>* P</i> < 0.05, <i>**P <</i> 0.01). (b) The time course of NF-M alternations in the spinal cord following EAE. Representative immunoblots of NF-M are also shown below the graph. The 0-day control is presented with 100%, the one of the treated groups is described with the percentage of 0-day control. The results are presented as a mean percentage of 0-day control ± SD. Statistical significance is determined by using one-way analysis of variance (ANOVA). The asterisk indicates statistical difference (<i>* P</i> < 0.05, <i>**P <</i> 0.01)